Skip to main content
SpringerLink
Log in

Reply to: Laffon and Marthan “FDG PET for therapy monitoring in Hodgkin’s and non-Hodgkin’s lymphomas: qPET versus rPET”

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Laffon E, Marthan R. FDG PET for therapy monitoring in Hodgkin's and non-Hodgkin's lymphomas: qPET versus rPET. Eur J Nucl Med Mol Imaging. 2017;44(9):1602–3.

    Article  PubMed  Google Scholar 

  2. Barrington SF, Kluge R. FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. Eur J Nucl Med Mol Imaging. 2017;44(Suppl 1):97–110.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Hasenclever D, Kurch L, Mauz-Körholz C, Elsner A, Georgi T, Wallace H, et al. qPET - a quantitative extension of the Deauville scale to assess response in interim FDG-PET scans in lymphoma. Eur J Nucl Med Mol Imaging. 2014;41(7):1301–8.

    Article  PubMed  Google Scholar 

  4. Annunziata S, Cuccaro A, Calcagni ML, Hohaus S, Giordano A, Rufini V. Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET). Ann Nucl Med. 2016;30:588–92.

    Article  CAS  PubMed  Google Scholar 

  5. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(Suppl 1):122S–50S.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, University Hospital of Leipzig, Liebigstrasse 18, 04103, Leipzig, Germany

    Regine Kluge & Lars Kurch

  2. PET Imaging Centre, King’s College London and Guy’s, King’s Health Partners, St. Thomas’ Hospital, Westminster Bridge Road, London, SE1 7EH, UK

    Sally Barrington

  3. Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Härtelstrasse 16-18, 04107, Leipzig, Germany

    Dirk Hasenclever

Authors
  1. Regine Kluge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sally Barrington
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lars Kurch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dirk Hasenclever
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Regine Kluge.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kluge, R., Barrington, S., Kurch, L. et al. Reply to: Laffon and Marthan “FDG PET for therapy monitoring in Hodgkin’s and non-Hodgkin’s lymphomas: qPET versus rPET”. Eur J Nucl Med Mol Imaging 44, 2331–2332 (2017). https://doi.org/10.1007/s00259-017-3826-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-017-3826-x

Search

Navigation